Conclusions Published in Alimentary Pharmacology & Therapeutics
One year on from the ground-breaking publication of the first Alimentary Pharmacology & Therapeutics (AP&T) supplement on GORD* (Gastro-Oesophageal Reflux Disease), leading clinical experts in the world of gastroenterology have once again congregated to review current thinking around GORD and its clinical significance.
A need for this second supplement, based on a series of presentations by eminent scientists and clinicians, was identified because of the continuing debate around the role that bile and pepsin play in the development and manifestations of GORD. Published with the September 2006 issue of AP&T, this stand alone supplement entitled "Bile and Pepsin – their role in GORD" explores the impact of bile and pepsin in clinical practice.
AP&T guest editor, Professor Pali Hungin, Dean of Medicine and Professor of Primary Care, University of Durham commented:
"A better understanding of the role of bile and pepsin in GORD will enable practising clinicians to tailor therapies more specifically, especially in those who do not respond to acid suppression measures."
GORD is recognised as a common condition and it is estimated that more than half of the UK population are affected at some time during their lives. One in ten of these patients endures significant problems and has a high tendency to relapse¹. Incomplete control of GORD is common and could be related to the shortcomings in our understanding of the non acid components of reflux, such as bile and pepsin. This new publication considers both the assessment and treatment of these difficult to treat, but all too common cases of GORD.
The latest AP&T supplement is the outcome of contributions from both primary and secondary care experts with international markets, including USA, The Netherlands, Belgium and the UK.
- GORD (UK) / GERD (US) – Gastro-oesophageal reflux disease
- Ends -
Notes to Editor:
The faculty comprises of internationally renowned key opinion leaders in the field of gastroenterology. Contributors of the supplement include:
• Professor Pali Hungin, Dean of Medicine and Professor of Primary Care, School for Health, University of Durham, Wolfson Research Unit, University Boulevard, Stockton-on-Tees, UK
• Professor James Mason, Professor of Health Economics, CIHCR, University of Durham, Stockton on Tees, UK
• Professor Brendan Delaney, Department of Primary Care, University of Birmingham, Birmingham, UK
• Dr Anan Raghunath, Centre for Integrated Health Care Research, Wolfson Research Institute, University of Durham, Stockton-on-Tees, UK
• Professor Jan Tack, Dept of Gastroenterology, Leuven, Belgium
• Dr Gert De Hertogh, Department of Morphology and Molecular Pathology, University Hospitals KUL, Leuven, Belguim
• Professor Donald Castell, Medical University of South Carolina, USA
• Dr Bob Heading, Consultant in Gastroenterology, UK
• Dr Norman Roberts, Dept of Clinical Biochemistry and Metabolic Medicine, Royal Liverpool University Hospital, Liverpool, UK
• Dr Abraham Botha, Consultant in General Surgery, St Thomas' Hospital, London, UK
• Professor Peter Dettmar, Managing Director, Technostics, London, UK
• Dr Richard Stevens, East Oxford Health Centre, London, UK
• Professor Andre Smout, Department of Gastroenterology, University Medical Centre, The Netherlands
• Dr Peter Ross, Ninewells Hospital, Dundee, UK
• Professor Massimo Pignatelli, Professor of Histopathology, University
of Bristol, UK
• Mr Dhiren Nehra, St. Anthony's Hospital, Surrey, UK
The faculty met to produce the GORD supplement at an international meeting on 25th March 2006, King's Fund, London, UK.
The supplement and meeting has been sponsored by an educational grant from Reckitt Benckiser.
For further information please contact:
Joanna Ferrier at hsdcommunications
Gable House, 40 High Street, Rickmansworth, Herts, WD3 1ER
Telephone: 01923 777277 Fax: 01923 777275